Inventor
CODY A. DESJARDINS
Inventor
US
Overview
Patents· 33 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
C07KPeptides29%
C12NMicroorganisms or enzymes21%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations19%
C12YEnzymes3%
PatentTitleYear
12,496,352Muscle targeting complexes and uses thereof for treating myotonic dystrophy202512,460,011Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of delivering an oligonucleotide to a subject202512,440,575Muscle targeting complexes and uses thereof for treating dystrophinopathies202512,440,574Muscle targeting complexes and formulations for treating myotonic dystrophy202512,428,487Complexes comprising an anti-transferrin receptor antibody linked to an oligonicleotide and method of delivering oligonucleotide to a subject202512,403,203Muscle targeting complexes and uses thereof for treating dystrophinopathies202512,397,062Muscle targeting complexes and uses thereof for treating dystrophinopathies202512,370,264Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of delivering oligonucleotide to a subject202512,329,824Muscle targeting complexes and uses thereof for treating dystrophinopathies202512,319,743Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of delivering oligonucleotide to a subject202512,280,122Muscle targeting complexes and uses thereof for treating myotonic dystrophy202512,239,716Muscle targeting complexes and uses thereof for treating dystrophinopathies202512,239,717Muscle targeting complexes and uses thereof for treating dystrophinopathies202512,173,078Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide202412,144,868Muscle targeting complexes and uses thereof for treating dystrophinopathies202412,144,867Muscle targeting complexes and uses thereof for treating dystrophinopathies202412,128,109Muscle targeting complexes and formulations for treating dystrophinopathies202412,102,687Muscle targeting complexes and uses thereof for treating myotonic dystrophy202412,097,263Muscle targeting complexes and uses thereof for treating myotonic dystrophy202412,018,087Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and methods of delivering oligonucleotide to a subject202411,986,537Muscle targeting complexes and uses thereof for treating dystrophinopathies202411,969,475Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy202411,931,421Muscle targeting complexes and formulations for treating myotonic dystrophy202411,911,484Muscle targeting complexes and uses thereof for treating myotonic dystrophy202411,844,843Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy202311,839,660Anti-transferrin receptor antibody and uses thereof202311,771,776Muscle targeting complexes and uses thereof for treating dystrophinopathies202311,759,525Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy202311,679,161Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy202311,672,872Anti-transferrin receptor antibody and uses thereof202311,648,318Anti-transferrin receptor (TFR) antibody and uses thereof202311,638,761Muscle targeting complexes and uses thereof for treating Facioscapulohumeral muscular dystrophy202311,633,498Muscle targeting complexes and uses thereof for treating myotonic dystrophy2023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023–2025Patents assigned to DYNE THERAPEUTICS INC (33)· patent assignee history
2023–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| DYNE THERAPEUTICS INC | 33 | 2023–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 33 | 2023–2025 |